Endocarditis: Difference between revisions
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 11: | Line 11: | ||
}} | }} | ||
{{endocarditis}} | {{endocarditis}} | ||
{{CMG}}; '''Associate Editor(s)-In-Chief:''' {{Maliha}}, {{CZ}}; [[Michael W. Tempelhof]] M.D., {{DN}} | {{CMG}}; '''Associate Editor(s)-In-Chief:''' {{Fs}}, {{Maliha}}, {{CZ}}; [[Michael W. Tempelhof]] M.D., {{DN}} | ||
{{SK}} Infective Endocarditis (IE); Subacute bacterial endocarditis (SBE); Acute bacterial endocarditis; Fungal endocarditis; Nosocomial infective endocarditis; Intravenous drug abuse endocarditis; Intravenous drug abuse infective endocarditis; Prosthetic valve endocarditis; Endocardial infection; Native valve endocarditis; HACEK endocarditis; Bloodstream infection | {{SK}} Infective Endocarditis (IE); Subacute bacterial endocarditis (SBE); Acute bacterial endocarditis; Fungal endocarditis; Nosocomial infective endocarditis; Intravenous drug abuse endocarditis; Intravenous drug abuse infective endocarditis; Prosthetic valve endocarditis; Endocardial infection; Native valve endocarditis; HACEK endocarditis; Bloodstream infection |
Latest revision as of 23:36, 12 December 2020
Resident Survival Guide |
Endocarditis | |
Mitral valve vegetations in a patient with bacterial endocarditis. |
Endocarditis Microchapters |
Diagnosis |
---|
Treatment |
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease |
Case Studies |
Endocarditis On the Web |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Fahimeh Shojaei, M.D., Maliha Shakil, M.D. [2], Cafer Zorkun, M.D., Ph.D. [3]; Michael W. Tempelhof M.D., Dima Nimri, M.D. [4]
Synonyms and keywords: Infective Endocarditis (IE); Subacute bacterial endocarditis (SBE); Acute bacterial endocarditis; Fungal endocarditis; Nosocomial infective endocarditis; Intravenous drug abuse endocarditis; Intravenous drug abuse infective endocarditis; Prosthetic valve endocarditis; Endocardial infection; Native valve endocarditis; HACEK endocarditis; Bloodstream infection
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Endocarditis for other Disorders
Risk Factors
Epidemiology and Demographics
Natural History, Complications, and Prognosis
Diagnosis
Diagnostic Criteria | History and Symptoms | Physical Examination and Signs | Laboratory Findings | Chest X Ray | Electrocardiogram | Cardiac MRI | CT | Echocardiography
Treatment
Medical Therapy | | Surgery | Antithrombotic Therapy | Primary Prevention | Secondary Prevention
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Diagnosis and Follow-up | Endocarditis Medical Therapy Guidelines | Endocarditis Intervention Guidelines